Related references
Note: Only part of the references are listed.Engineered nanoparticles mimicking cell membranes for toxin neutralization
Ronnie H. Fang et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Hydrogel Retaining Toxin-Absorbing Nanosponges for Local Treatment of Methicillin-Resistant Staphylococcus aureus Infection
Fei Wang et al.
ADVANCED MATERIALS (2015)
Biomimetic nanoassembly for targeted antigen delivery and enhanced Th1-type immune response
Zhenhua Li et al.
CHEMICAL COMMUNICATIONS (2015)
Modulating Antibacterial Immunity via Bacterial Membrane-Coated Nanoparticles
Weiwei Gao et al.
NANO LETTERS (2015)
Nanoparticle biointerfacing by platelet membrane cloaking
Che-Ming J. Hu et al.
NATURE (2015)
Nanoparticle-Based Manipulation of Antigen-Presenting Cells for Cancer Immunotherapy
Ronnie H. Fang et al.
SMALL (2015)
Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance
Lang Rao et al.
SMALL (2015)
Engineered CpG- Antigen Conjugates Protected Gold Nanoclusters as Smart Self- Vaccines for Enhanced Immune Response and Cell Imaging
Yu Tao et al.
ADVANCED FUNCTIONAL MATERIALS (2014)
Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
Ronnie H. Fang et al.
NANO LETTERS (2014)
Clearance of pathological antibodies using biomimetic nanoparticles
Jonathan A. Copp et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
TETANUS TOXOID, DIPHTHERIA TOXOID, AND ACELLULAR PUERTUSSIS (TDAP) VACCINE COMPLIANCE AMONG ADOLESCENTS IN THE UNITED STATES
S. Kurosky et al.
VALUE IN HEALTH (2014)
Gram-positive and gram-negative bacterial toxins in sepsis A brief review
Girish Ramachandran
VIRULENCE (2014)
Staphylococcal Bicomponent Pore-Forming Toxins: Targets for Prophylaxis and Immunotherapy
M. Javad Aman et al.
TOXINS (2014)
Nanoparticle-detained toxins for safe and effective vaccination
Che-Ming J. Hu et al.
NATURE NANOTECHNOLOGY (2013)
A biomimetic nanosponge that absorbs pore-forming toxins
Che-Ming J. Hu et al.
NATURE NANOTECHNOLOGY (2013)
Structurally Designed Attenuated Subunit Vaccines for S. aureus LukS-PV and LukF-PV Confer Protection in a Mouse Bacteremia Model
Hatice Karauzum et al.
PLOS ONE (2013)
Combination Delivery of Antigens and CpG by Lanthanides-Based Core-Shell Nanoparticles for Enhanced Immune Response and Dual-Mode Imaging
Zhenhua Li et al.
ADVANCED HEALTHCARE MATERIALS (2013)
Staphylococcus aureus α-Toxin: Nearly a Century of Intrigue
Bryan J. Berube et al.
TOXINS (2013)
Engineering Nano- and Microparticles to Tune Immunity
James J. Moon et al.
ADVANCED MATERIALS (2012)
Biomimetic Delivery with Micro- and Nanoparticles
Stephen C. Balmert et al.
ADVANCED MATERIALS (2012)
Contribution of Toll-like receptor signaling to germinal center antibody responses
Anthony L. DeFranco et al.
IMMUNOLOGICAL REVIEWS (2012)
Antigen-Displaying Lipid-Enveloped PLGA Nanoparticles as Delivery Agents for a Plasmodium vivax Malaria Vaccine
James J. Moon et al.
PLOS ONE (2012)
Novel Structurally Designed Vaccine for S. aureus α-Hemolysin: Protection against Bacteremia and Pneumonia
Rajan P. Adhikari et al.
PLOS ONE (2012)
Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction
James J. Moon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Expectations Regarding Vaccines and Immune Therapies Directed Against Staphylococcus aureus α-Hemolysin
Douglas S. Kernodle
JOURNAL OF INFECTIOUS DISEASES (2011)
Tackling antibiotic resistance
Karen Bush et al.
NATURE REVIEWS MICROBIOLOGY (2011)
Current Concepts in Antimicrobial Therapy Against Select Gram-Positive Organisms: Methicillin-Resistant Staphylococcus aureus, Penicillin-Resistant Pneumococci, and Vancomycin-Resistant Enterococci
Ana Maria Rivera et al.
MAYO CLINIC PROCEEDINGS (2011)
Immunity against Staphylococcus aureus cutaneous infections
Lloyd S. Miller et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Basis of Virulence in Community-Associated Methicillin-Resistant Staphylococcus aureus
Michael Otto
ANNUAL REVIEW OF MICROBIOLOGY, VOL 64, 2010 (2010)
Serious Infections Caused by Methicillin-Resistant Staphylococcus aureus
Helen Boucher et al.
CLINICAL INFECTIOUS DISEASES (2010)
Tetanus toxoid immunization to reduce mortality from neonatal tetanus
Hannah Blencowe et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2010)
Targeting of Alpha-Hemolysin by Active or Passive Immunization Decreases Severity of USA300 Skin Infection in a Mouse Model
Adam D. Kennedy et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Anti-virulence strategies to combat bacteria-mediated disease
David A. Rasko et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus
Min Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Vaccine protection against Staphylococcus aureus pneumonia
Juliane Bubeck Wardenburg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Lysostaphin as a treatment for systemic Staphylococcus aureus infection in a mouse model
John F. Kokai-Kun et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Targeting virulence: a new paradigm for antimicrobial therapy
Anne E. Clatworthy et al.
NATURE CHEMICAL BIOLOGY (2007)
Antigen-specific memory B cell development
LJ McHeyzer-Williams et al.
ANNUAL REVIEW OF IMMUNOLOGY (2005)
The global impact of drug resistance
DH Howard et al.
CLINICAL INFECTIOUS DISEASES (2003)
Share Paper
